Richard Segal

Partner
Full contact info

I bring experience, practicality, and a lot of energy to make transformative capital markets transactions smooth, painless and fun.

Passions

Big mountains

Deep snow

Experience

Zenas BioPharma Announces $225 Million IPO

September 16, 2024

Cooley advised Morgan Stanley, Jefferies, Citigroup and Guggenheim Securities as the underwriters of Zenas BioPharma’s $225 million initial public offering.

Read more

Related contacts

Richard Segal
Partner, New York
Denny Won
Partner, San Francisco
Div Gupta
Partner, New York
Evan Leitner
Associate, New York
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Austin Holt
Partner, Santa Monica
David Peinsipp
Partner, San Francisco
Dr. Madhuri Roy
Partner, Palo Alto
Geoffrey Spolyar
Partner, Boston
Francis Wheeler
Partner, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Nathaniel Hearn Jr.
Associate, Chicago
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Aaron Level
Associate, New York
Brenna McGuire
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Jesse Schulman
Associate, Colorado
Nitasha Bennett
Patent Agent, San Diego
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

Alarm.com – $500 Million Convertible Notes Offering

June 3, 2024

Cooley advised Alarm.com Holdings, a platform for the intelligently connected property, on its $500 million convertible note offering.

Read more

Related contacts

Mike Lincoln
Vice Chair, Reston
Richard Segal
Partner, New York
Natalie Karam
Partner, Palo Alto
Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Eileen Marshall
Partner, Washington, DC
Timothy Shapiro
Partner, Palo Alto
Katherine Denby
Associate, Washington, DC
Timothy Nguyen
Special Counsel, San Francisco
Charles York
Associate, New York
Charlotte Yin
Associate, New York
Victoria Comesañas
Associate, Palo Alto
Stevie Yu
Associate, New York
Calvin Lee
Associate, New York
Chris Rhem
Paralegal Specialist, San Francisco
Jill Simon
Senior Paralegal, New York

Related Practices & Industries

Silvaco Announces $114 Million IPO

May 13, 2024

Cooley advised the underwriters of Silvaco, a leading provider of technology computer-aided design (TCAD), electronic design animation (EDA) software, and session initiation protocol (SIP) solutions that enable semiconductor design and artificial intelligence through software and innovation, on its $114 million initial public offering.

Read more

Related contacts

Eric Jensen
Vice Chair, Palo Alto
Richard Segal
Partner, New York
Darah Protas
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Mark Lambert
Partner, Palo Alto
Eileen Marshall
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
Nyron J. Persaud
Partner, New York
Scott Weston
Partner, Boston
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kassity L. Mai
Special Counsel, Reston
Kimberly Nguyen
Special Counsel, Reston
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Peter Burns
Of Counsel, Palo Alto
Mor Agam
Associate, New York
Anitha Anne
Associate, San Francisco
Chris Chynoweth
Associate, New York
Megan Drill
Associate, San Diego
Katherine King
Associate, Washington, DC
Allison Kutner
Associate, New York
Evan Leitner
Associate, New York
Kristin R. Marshall
Associate, Washington, DC
Greg Merchant
Associate, Palo Alto
Anisha Mohin
Associate, New York
Charles York
Associate, New York
Margie Murphy
Paralegal Specialist, New York

Related Practices & Industries

Cidara Therapeutics Announces Concurrent Reacquisition of IP Rights to CD388, $240 Million PIPE Financing

May 1, 2024

Cooley advised Cidara Therapeutics (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak platform to develop drug-Fc conjugate immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, on its concurrent $240 million private placement financing and definitive agreement with Janssen Pharmaceuticals, a Johnson & Johnson Company, to reacquire the exclusive global development and commercial rights to CD388.

Read more

Related contacts

Charles Bair
Partner, San Diego
Jane Adams
Partner, San Diego
Barbara Borden
Partner, San Diego
Megan Browdie
Partner, Washington, DC
Daniel I. Goldberg
Partner, New York
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Francis Wheeler
Partner, Colorado
Sharon Connaughton
Special Counsel, Washington, DC
Asa Henin
Special Counsel, San Diego
Alexis Guillermo Buz
Associate, San Diego
Gaël Y. Hagan
Associate, Colorado
Michelle Hunt
Associate
Edmond Lay
Associate, San Diego
Kyrsten Lundh
Associate, San Diego
Jayden Martinez
Associate, Colorado
Amanda Pacheco
Associate, Palo Alto
Valerie Sapozhnikova
Associate, Los Angeles
Kelly Nelle
Paralegal Specialist, San Diego

Related Practices & Industries

Abivax Announces $235.8 Million IPO

October 20, 2023

Cooley advised Abivax, a clinical-stage biotech company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, on its $235.8 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Ryan Sansom
Partner, Boston
Denny Won
Partner, San Francisco
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Nyron J. Persaud
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Courtney Thorne
Partner, London
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Kevin King
Partner, Washington, DC
Katie Kazem
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Minkyu Park
Associate, New York
Jesse Schulman
Associate, Colorado
Barry Kuang
Associate, Boston
Olivia Creser
Associate, New York
Peter A. Haddad
Associate, San Diego
Samuel Paullin
Associate, Chicago
Evan Leitner
Associate, New York
Rick Jantz
Associate, Santa Monica
Cara Buchicchio
Associate, New York
Dr. Jason Valentine
Associate, Washington, DC
Jessica Koffel
Associate, Brussels
Mor Agam
Associate, New York
Cathy Rude
Paralegal Specialist, Boston

Related Practices & Industries

View more

Admissions and credentials

New York

Massachusetts

Rankings and accolades

Chambers USA: Capital Markets: Debt & Equity – Eastern United States – Nationwide (2023 – 2024)

Chambers USA: Capital Markets – Massachusetts (2020 – 2022)

The Legal 500 US: Next Gen Partner for Capital Markets: Equity Offerings (2021 – 2023)

Massachusetts Super Lawyers: Rising Star – Securities & Corporate Finance (2013 – 2022)

The level of diligence Rich has is beyond impressive and he works through some of the most complex matters.

Chambers USA, 2024

He has incredibly deep knowledge and is incredibly sophisticated in finding the right way to move forward.

Chambers USA, 2024